Cherease Oliver

Cherease Oliver is an accomplished accounting professional currently serving as Accounting Manager at SpringWorks Therapeutics since August 2021, where the focus is on advancing drug development for rare diseases and cancer. Prior to this role, Cherease held positions as Accounting Supervisor and Senior Accountant at BIC from October 2016 to August 2021, and worked for Wexford Capital LP from September 2003 to May 2015 in various accounting and operations roles. Cherease holds a Bachelor's degree in Finance from Sacred Heart University and an Associate's degree in Liberal Arts and Sciences from CT State Norwalk.